Faslodex

In the US, Faslodex (fulvestrant systemic) is a member of the following drug classes: estrogen receptor antagonists, hormones/antineoplastics and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:

• Faslodex

UK matches:

• Faslodex 250 mg solution for injection.
• Faslodex 250 mg solution for injection (SPC)

Ingredient matches for Faslodex

Fulvestrant

Fulvestrant is reported as an ingredient of Faslodex in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Canada


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Egypt


• Finland


• France


• Georgia


• Germany


• Greece


• Hungary


• Iceland


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Jordan


• Kuwait


• Lebanon


• Luxembourg


• Netherlands


• New Zealand


• Norway


• Oman


• Portugal


• Qatar


• Russian Federation


• Saudi Arabia


• South Africa


• Spain


• Sweden


• Switzerland


• Syria


• Taiwan


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.